Quality assessment of compounded 17-hydroxyprogesterone caproate

Am J Obstet Gynecol. 2014 Jan;210(1):47.e1-7. doi: 10.1016/j.ajog.2013.09.039. Epub 2013 Nov 4.

Abstract

Objective: The purpose of this study was to evaluate the quality of compounded 17-hydroxyprogesterone caproate (17-OHPC).

Study design: Compounded 17-OHPC that was obtained from 15 compounding pharmacies throughout the United States was analyzed for potency, impurities, sterility, and pyrogen status.

Results: Eighteen samples were supplied by 15 compounding pharmacies. The concentration of 17-OHPC in all samples was within the specification limits, and all tested samples passed sterility and pyrogen testing. Only 1 of 18 samples was out of specification limits for impurities.

Conclusion: Compounded 17-OHPC that was obtained from 15 pharmacies throughout the United States did not raise safety concerns when assessed for potency, sterility, pyrogen status, or impurities.

Keywords: compounded 17-OHPC; impurity analysis; potency; sterility and pyrogen status.

Publication types

  • Evaluation Study
  • Research Support, N.I.H., Extramural

MeSH terms

  • 17 alpha-Hydroxyprogesterone Caproate
  • Drug Compounding / standards*
  • Humans
  • Hydroxyprogesterones / analysis
  • Hydroxyprogesterones / standards*
  • Pyrogens
  • Quality Assurance, Health Care
  • Quality Control
  • United States

Substances

  • Hydroxyprogesterones
  • Pyrogens
  • 17 alpha-Hydroxyprogesterone Caproate